Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Worth further discussion..
View:
Post by canadafan on Jan 02, 2024 1:17pm

Worth further discussion..

I posted some relevant, accurate & timely updates a few days ago.
Interestingly overwritten by for the most part, relevant to the biotech industry, but not directly related to Onc.
So:  I'll try this again.
1. The Onc San Diego office is up for lease. 

2. The V.P of USA business & development has left the company. He took his options & left. Early December.
3. Onc has said nothing about this change. Andrew G. Is now gone from the " mangement" page of their web site.
obviouoy they are closing the USA footprint.
Why?
& why no updates?

Obviously something is in- process. Not a random sequence of events.
My continued speculation is that of a buyout. Requiring a NDA & news blackout.
other options are plentry.

regardless I'm surprised ( there is that word again), no update today.
BTW, since inception & incorporation & part of corporate stratagy has always been to get Pela far enough & then partner or sell. 

" going it alone" Would require not only huge funds, but also a complete rewrite of corporate direction.
up to & including the $350million shelf prospectus...would need to be rewritten, approved by board.

That option imho is a non- starter.
regardless, stay tuned. 

Has been a very long ride. The next chapter will be revealed very soon.
As an investor new, old, or just not yet?
The science looks good. Roche is in deep with gobblet.
The business model moving forward?
it can not continue as- is for much longer.
Could be a truly binary investment right now. Quick resolution & upside. Or middle of the road re- organization.
again my opinion & thoughts. The buyout is at the lawyer & accountant stage.
Andrew left for greener pastures. Not needed in the new format.
The new hire positions? Obviously part of the future plans.

Comment by fasttrack5 on Jan 02, 2024 1:30pm
I would be extacic with buyout. roll it out. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities